Notice of NIDCD Withdrawal from Participation in PAR-18-214 "Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)"

Notice Number: NOT-DC-18-004

Key Dates
Release Date: January 10, 2018

Related Announcements
PAR-18-214

Issued by
National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

TheĀ  purpose of this Notice is to inform applications that as of the April 4, 2018 due date NIDCD will no longer participate in theĀ  Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional) (PAR-18-214), and will not accept any applications to the Funding Opportunity Announcement (FOA) PAR-18-214.

Currently reads:

Components of Participating Organizations
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.865; 93.173 

Modified to read:

Components of Participating Organizations
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.865

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Dr. Susan Sullivan
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-451-3841
Email: sullivas@nidcd.nih.gov